CARLSBAD, Calif. — June 24, 2015 —Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals, has earned the USDA Certified Biobased Product Label for BIOLON™ dodecanedioc acid (DDDA). The USDA Certified Biobased Product Label verifies that the product’s amount of renewable biobased ingredients meets or exceeds levels set by USDA. Biobased products are finished or intermediate materials composed in whole or in significant part of agricultural, forestry, or marine ingredients.
“We are very gratified to have earned the USDA Certified Biobased Product Label for our first product, BIOLON™ DDDA,” said E. William Radany, Ph.D, President and CEO of Verdezyne. “Moreover, having recently signed a distribution agreement for BIOLON™ DDDA in Europe, the timing couldn’t be better. We see this certification as a key differentiator for our product.”
All biobased amount claims are verified by independent labs and monitored by the USDA. Consumers may feel secure in the accuracy of the biobased amount and be empowered in making better informed purchasing decisions.
“We are proud that Verdezyne, Inc. has earned the USDA Certified Biobased Product Label,” said Ron Buckhalt, USDA BioPreferred Program Manager. “Biobased products add value to renewable agriculture commodities, create jobs in rural communities and help our nation decrease its reliance on foreign-sourced and non-renewable petroleum.”
Following is an example of the label:
About USDA BioPreferred
The USDA BioPreferred program was created by the Farm Security and Rural Investment Act of 2002 (2002 Farm Bill), and expanded by the Food, Conservation, and Energy Act of 2008 (2008 Farm Bill). The purpose is to increase the purchase and use of biobased products. The United States Department of Agriculture manages the program. Products that meet the USDA BioPreferred program requirements carry a distinctive label for easier identification by the consumer. To learn more about the USDA Certified Biobased Product Label please visit www.biopreferred.gov, and follow on Twitter: @BioPreferred.
Verdezyne is an industrial biotechnology company using proprietary metabolic pathway engineering tools to develop unique yeast strains for production of biobased chemicals. Current investors in Verdezyne include BP Alternative Energy Ventures, DSM Venturing B.V., OVP Venture Partners, Monitor Ventures, and Sime Darby. For more information, visit www.verdezyne.com or connect with the company on Twitter, LinkedIn or Facebook.